Notably, mutant KRAS is the most frequent driver of several cancers (COSMIC, 2024; Punekar et al., 2022): about 27% of all human cancers, 45% of colorectal, and 90% of pancreatic cancers (Merz et al., 2021). Here, KRAS is linked to cancer.